Vita Life Sciences Ltd (VLS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.125x

Based on the latest financial reports, Vita Life Sciences Ltd (VLS) has a cash flow conversion efficiency ratio of 0.125x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$6.60 Million ≈ $4.67 Million USD) by net assets (AU$52.62 Million ≈ $37.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See VLS equity financing ratio to measure how much of total assets are equity-financed.

Vita Life Sciences Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Vita Life Sciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Vita Life Sciences Ltd to evaluate the quality of earnings relative to operating cash generation.

Vita Life Sciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vita Life Sciences Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Asefa Public Company Limited BK:ASEFA	0.121x
Catur Sentosa Adiprana Tbk JK:CSAP	-0.006x
Samyang Packaging KO:272550	0.045x
Semen Baturaja Persero Tbk JK:SMBR	0.008x
Niching Industrial TWO:3444	0.087x
Global Lithium Resources Ltd AU:GL1	-0.020x
Rafael Holdings, Inc. NYSE:RFL	-0.090x
DMS Propertindo Tbk PT JK:KOTA	-0.003x

Annual Cash Flow Conversion Efficiency for Vita Life Sciences Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Vita Life Sciences Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Vita Life Sciences Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$52.28 Million ≈ $36.99 Million	AU$6.16 Million ≈ $4.36 Million	0.118x	-60.71%
2023-12-31	AU$43.33 Million ≈ $30.66 Million	AU$12.98 Million ≈ $9.19 Million	0.300x	+294.10%
2022-12-31	AU$36.50 Million ≈ $25.83 Million	AU$2.77 Million ≈ $1.96 Million	0.076x	-60.73%
2021-12-31	AU$30.42 Million ≈ $21.53 Million	AU$5.89 Million ≈ $4.17 Million	0.194x	-37.28%
2020-12-31	AU$24.44 Million ≈ $17.29 Million	AU$7.54 Million ≈ $5.34 Million	0.309x	+242.94%
2019-12-31	AU$22.53 Million ≈ $15.94 Million	AU$2.03 Million ≈ $1.43 Million	0.090x	-29.04%
2018-12-31	AU$22.41 Million ≈ $15.85 Million	AU$2.84 Million ≈ $2.01 Million	0.127x	-2.28%
2017-12-31	AU$24.79 Million ≈ $17.54 Million	AU$3.22 Million ≈ $2.28 Million	0.130x	-36.14%
2016-12-31	AU$23.18 Million ≈ $16.40 Million	AU$4.71 Million ≈ $3.33 Million	0.203x	-5.56%
2015-12-31	AU$22.88 Million ≈ $16.19 Million	AU$4.92 Million ≈ $3.48 Million	0.215x	-24.11%
2014-12-31	AU$21.57 Million ≈ $15.26 Million	AU$6.12 Million ≈ $4.33 Million	0.284x	-4.59%
2013-12-31	AU$16.27 Million ≈ $11.51 Million	AU$4.83 Million ≈ $3.42 Million	0.297x	+143.73%
2012-12-31	AU$11.34 Million ≈ $8.03 Million	AU$1.38 Million ≈ $978.56K	0.122x	-80.71%
2011-12-31	AU$8.96 Million ≈ $6.34 Million	AU$5.66 Million ≈ $4.01 Million	0.632x	+712.81%
2010-12-31	AU$8.13 Million ≈ $5.75 Million	AU$-838.65K ≈ $-593.40K	-0.103x	+83.17%
2009-12-31	AU$3.90 Million ≈ $2.76 Million	AU$-2.39 Million ≈ $-1.69 Million	-0.613x	-515.31%
2008-12-31	AU$3.85 Million ≈ $2.72 Million	AU$567.42K ≈ $401.48K	0.148x	-43.35%
2007-12-31	AU$2.88 Million ≈ $2.04 Million	AU$750.00K ≈ $530.67K	0.260x	+68.96%
2006-12-31	AU$3.35 Million ≈ $2.37 Million	AU$516.00K ≈ $365.10K	0.154x	--

About Vita Life Sciences Ltd

AU:VLS Australia Drug Manufacturers - Specialty & Generic

Market Cap

$95.85 Million

AU$135.46 Million AUD

Market Cap Rank

#19319 Global

#621 in Australia

Share Price

AU$2.48

Change (1 day)

+0.00%

52-Week Range

AU$2.16 - AU$2.83

All Time High

AU$2.83